Vestmark Advisory Solutions’s Amicus Therapeutics FOLD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-367,153
Closed -$5.31M – 1488
2026
Q1
$5.31M Sell
367,153
-404
-0.1% -$5.79K 0.06% 334
2025
Q4
$5.23M Buy
+367,557
New +$3.61M 0.07% 284

Other funds holding FOLD

Vestmark Advisory Solutions's FOLD Position: Q2 2026 in Review

Vestmark Advisory Solutions sold out of Amicus Therapeutics (FOLD) in Q2 2026, closing a stake of 367,153 shares — an estimated $5.31M sold.

Vestmark Advisory Solutions first reported a position in FOLD in Q4 2025 and held it in 2 quarters. The position peaked at $5.31M in Q1 2026. 2 funds tracked by Wall St. Rank hold FOLD as of Q2 2026.

  • Vestmark Advisory Solutions reported no remaining Amicus Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Vestmark Advisory Solutions sold 367,153 Amicus Therapeutics shares in Q2 2026, an estimated $5.31M.
  • Vestmark Advisory Solutions first reported a position in Amicus Therapeutics in Q4 2025 and held it in 2 quarters.
  • Vestmark Advisory Solutions's Amicus Therapeutics position peaked at $5.31M in Q1 2026.
  • 2 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2026.

Based on Vestmark Advisory Solutions's 13F filing for Q2 2026, filed 14 Aug 2026.